Plasma sulfoconjugated dopamine levels are normal in patients with autonomic failure

Journal of Laboratory and Clinical Medicine

Volumn 128, Issue 5, 1996, Pages 488-491

  Yamamoto, Toshimasa ^b   Polinsky, Ronald J ^b   Goldstein, David S ^b   Baucom, Celeste E ^b   Kopin, Irwin J ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030282519     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(96)90045-1     Document Type: Article

References (19)

1. Snider SR, Kuchel O. Dopamine: an important neurohormone of the sympathoadrenal system. Significance of increased peripheral dopamine release for the human stress response and hypertension. Endocr Rev 1983;4:291-309.
2. Kuchel O. Stress and catecholamines. Methods Achieve Exp Pathol 1991;14:80-103.
3. Sagnol M, Claustre J, Cottet-Emard JM, et al. Plasma free and sulphated catecholamines after ultra-long exercise and recovery. Eur J Appl Physiol 1990;60:91-7.
4. Eldrup E, Hagen C, Christensen NJ, Igaard K. Plasma free and sulfoconjugated dopamine in man: relationship to sympathetic activity, adrenal function and meals. Dan Med Bull 1988;35:291-4.
5. Hashizume K, Yamatodani A, Yamamoto T, Ogihara T, Kumahara Y, Wada H. Effects of oral and intravenous administrations of dopamine and L-dopa on plasma levels of two isomers of dopamine sulfate in man. Life Sci 1987;41: 2697-704.
6. Ratge D, Gehrke A, Melzner I, Wisser H. Free and conjugated catecholamines in human plasma during physical exercise. Clin Exp Pharmacol Physiol 1986;13:543-53.
7. Shibata O, Morooka H, Hara K, Hasheba S, Gotoh Y, Ozaki M. Free and conjugated catecholamine concentrations in human small intestine following exogenous free dopamine administration. Biogenic Amines 1987;4:465-72.
8. Ziegler MG, Lake CR, Kopin IJ. The sympathetic-nervous-system defect in primary orthostatic hypotension. N Engl J Med 1977;296:293-7.
9. Dotson R, Ochoa J, Marchettini P, Cline M. Sympathetic neural outflow directly recorded in patients with primary autonomic failure: clinical observations, microneurography, and histopathology. Neurology 1990;40:1079-85.
10. Goldstein DS, Polinsky RJ, Garty M, et al. Patterns of plasma levels of catechols in neurogenic orthostatic hypotension. Ann Neurol 1989;26:558-63.
11. Polinsky RJ, Kopin IJ, Ebert MH, Weise V. Pharmacologic distinction of different orthostatic hypotension syndromes. Neurology 1981;31:1-7.
12. Eisenhofer G, Goldstein DS, Stull R, et al. Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem 1986;32:2030-3.
13. Van Loon GR. Plasma dopamine: regulation and significance. Fed Proc 1983;42:3012-8.
14. Kopin IJ. Origins and significance of dopa and catecholamine metabolites in body fluids. Pharmacopsychiatry 1992;25:33-6.
15. Cuche JL, Prinseau J, Selz F, et al. Oral load of tyrosine or L-dopa and plasma levels of free and sulfoconjugated catecholamines in healthy men. Hypertension 1985;7:81-9.
16. Buu NT, Duhaime J, Kuchel O. Effects of L-dopa on the concentrations of free and sulfoconjugated catecholamines in plasma, cerebrospinal fluid, urine, and central and peripheral nervous system tissues of the rat. J Neurochem 1985;44:787-92.
17. Gaudin C, Braillon A, Selz F, Cuche JL, Lebrec D. Free and conjugated catecholamines in patients with cirrhosis. J Lab Clin Med 1990;115:589-92.
18. Tyce GM, Van Dyke RA, Rettke SR, et al. Human liver and conjugation of catecholamines. J Lab Clin Med 1987;109: 532-7.
19. Cuche JL, Safar M. Potential role of the renal tubule in fixing the level of plasma sulfoconjugated catecholamines in the dog. J Lab Clin Med 1992;119:391-6.